BRKR - Bruker Corp Stock Price, Fair Value and News

$56.65+0.43 (+0.76%)

Delayed as of 22 Nov 2024, 01:02 pm ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

BRKR Price Action

Last 7 days

3.2%

Last 30 days

-7.1%

Last 90 days

-12.4%

Trailing 12 Months

-13.6%

BRKR RSI Chart

BRKR Valuation

Market Cap

8.5B

Price/Earnings (Trailing)

22.84

Price/Sales (Trailing)

3.06

EV/EBITDA

Price/Free Cashflow

54.39

BRKR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

BRKR Fundamentals

BRKR Revenue

Revenue (TTM)

3.0B

Rev. Growth (Yr)

16.37%

Rev. Growth (Qtr)

7.96%

BRKR Earnings

Earnings (TTM)

401.6M

Earnings Growth (Yr)

-53.58%

Earnings Growth (Qtr)

438.16%

BRKR Profitability

Operating Margin

44.86%

EBT Margin

13.05%

Return on Equity

22%

Return on Assets

6.57%

Free Cashflow Yield

1.84%

BRKR Investor Care

Dividend Yield

0.36%

Dividend/Share (TTM)

0.2

Shares Dilution (1Y)

9.53%

Diluted EPS (TTM)

2.07

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	3.0B	0	0	0
2023	2.6B	2.7B	2.8B	3.0B
2022	2.5B	2.5B	2.5B	2.5B
2021	2.1B	2.3B	2.4B	2.4B
2020	2.0B	2.0B	2.0B	2.0B
2019	1.9B	2.0B	2.0B	2.1B
2018	1.8B	1.8B	1.9B	1.9B
2017	1.6B	1.7B	1.7B	1.8B
2016	1.6B	1.6B	1.6B	1.6B
2015	1.7B	1.7B	1.7B	1.6B
2014	1.9B	1.9B	1.9B	1.8B
2013	1.8B	1.8B	1.8B	1.8B
2012	1.7B	1.7B	1.7B	1.8B
2011	1.4B	1.5B	1.6B	1.7B
2010	1.2B	1.2B	1.3B	1.3B

Get all data in R, Python etc through our Historical Stock Data APIs

About Bruker Corp

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

CEO	Dr. Frank H. Laukien Ph.D.
WEBSITE	bruker.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	8525

Bruker Corp Frequently Asked Questions

What is the ticker symbol for Bruker Corp? What does BRKR stand for in stocks?

BRKR is the stock ticker symbol of Bruker Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Bruker Corp (BRKR)?

As of Thu Nov 21 2024, market cap of Bruker Corp is 8.52 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BRKR stock?

You can check BRKR's fair value in chart for subscribers.

Is Bruker Corp a good stock to buy?

The fair value guage provides a quick view whether BRKR is over valued or under valued. Whether Bruker Corp is cheap or expensive depends on the assumptions which impact Bruker Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BRKR.

What is Bruker Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Nov 21 2024, BRKR's PE ratio (Price to Earnings) is 22.84 and Price to Sales (PS) ratio is 3.06. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BRKR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Bruker Corp's stock?

In the past 10 years, Bruker Corp has provided 0.113 (multiply by 100 for percentage) rate of return.